INFANTILE FIBROSARCOMA
Clinical trials for INFANTILE FIBROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new INFANTILE FIBROSARCOMA trials appear
Sign up with your email to follow new studies for INFANTILE FIBROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for kids with rare, Hard-to-Treat cancers
Disease control OngoingThis study tests an oral drug called LOXO 292 in children and teens with advanced solid or brain tumors that have a specific genetic change (RET alteration). The goal is to see if the drug can shrink tumors or stop them from growing. About 36 participants will receive the drug, a…
Matched conditions: INFANTILE FIBROSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 07:38 UTC
-
New drug shows promise for rare childhood cancers
Disease control OngoingThis study tests a drug called larotrectinib in children and young adults with certain cancers that have a specific genetic change called a TRK fusion. The goal is to see if the drug can shrink tumors or control the cancer. About 33 participants with solid tumors or relapsed leuk…
Matched conditions: INFANTILE FIBROSARCOMA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 04, 2026 16:23 UTC